TREM2 and Alzheimer disease: GWAS revealed TREM2 SNPs to increase AD risk by 2–4 times (McQuade and Blurton-Jones, 2019), in addition to accelerating cognitive decline (Rajagopalan et al., 2013; Replogle et al., 2015).